Insights for Connected, AI-Actionable Life Sciences
Explore the latest ideas shaping life sciences, with expert perspectives on agentic AI, operating system, architecture, contextualized data, and connected operations.
Tech Transfer Doesn’t Have to Take Months. Here’s What’s Actually Broken.
Moving a process from development into manufacturing still takes months. Marcia Blackmoore argues the cause is process knowledge treated as documents, and explains what changes when recipes become structured, versioned data.
Blog Posts.
Beyond the Limits of LIMS: Why Life Sciences Needs a Unifying Platform Approach
This blog explores the limitations of traditional legacy LIMS and the challenges of integrating disparate systems. To overcome these, it introduces the unifying platform approach, highlighting how L7|ESP enables orchestration, contextualized data, and scalability across research, development, and manufacturing—empowering organizations to drive true digital transformation and prepare for AI-driven innovation.
Stop Feeding AI Junk Data: The Role of Data Contextualization in Smarter Manufacturing
Traditional MES systems weren’t built for AI. In this post, Kevin McMahon explores how manufacturers can overcome rigid, siloed systems by embracing data orchestration and contextualization. Discover how platforms like L7|ESP® transform MES into a foundation for AI-driven insight, automation, and smarter decision-making across life sciences manufacturing.
Fixing AI’s Blind Spot: The Role of Knowledge Graphs in Life Sciences
AI without data context is just guesswork. Life sciences organizations are investing in AI, but fragmented, unstructured data is holding them back. In this POV from Vasu Rangadass, Ph.D., discover how knowledge graphs and unifying platforms create trust, accuracy, and AI-driven impact.
L7 Informatics and Waters Corporation Partner to Seamlessly Connect Waters’ Informatics Solutions with L7|ESP®
L7 and Waters have joined forces to integrate Waters’ informatics solutions with L7|ESP®, enhancing lab automation, real-time analytics, and AI-driven workflow optimization. This partnership enables seamless data connectivity, driving process orchestration and continuous manufacturing advancements for pharmaceutical and life sciences organizations worldwide.
Bridging the AI Chasm in Life Sciences: Why Orchestration Platforms Are the Key to Intelligence
AI in life sciences is only as good as the data it’s built on. In this POV by Vasu Rangadass, Ph.D., discover why orchestration platforms are the missing link between fragmented IT systems and AI-ready knowledge, enabling true Agentic AI and intelligent automation. Learn how leading pharma companies are transforming operations with a structured approach…
Building the Future of Cell Therapy: How Cellipont Bioservices Transformed Manufacturing Through Enhanced Quality and Operational Efficiency with a Unifying Platform
Paper-based workflows slow progress in cell therapy manufacturing. For Cellipont, the solution was clear: digital transformation with L7|ESP. By replacing manual inefficiencies with streamlined, automated processes, Cellipont improved quality, compliance, and operational efficiency—setting a new industry standard. Learn how they achieved a fully digitalized, future-ready manufacturing ecosystem.
Unleashing the Power of Gen AI: It’s All About the Data
Generative AI is transforming life sciences, but its success depends on high-quality, structured data. Read the blog post and learn how contextualized data, knowledge graphs, and ontology integration enhance AI performance and drive innovation.
Breaking Down Data Silos in Life Sciences for Smarter AI
In this POV, Vasu Rangadass, Ph.D., explains why a unifying platform approach is key to achieving smarter AI, streamlined workflows, and real-time insights that transform R&D and manufacturing operations.
Why Disruptive Technology is the Key to Transforming Life Sciences
L7 and Zaether discuss the critical role of disruptive technology in reshaping life sciences. From breaking silos to enabling AI-driven insights and streamlining tech transfer, their partnership offers a path toward systemic transformation. Learn how unified platforms and collaboration accelerate innovation and improve patient outcomes.
Scaling Biomanufacturing for the Future: Why Data as an Asset is Non-Negotiable
In this POV, Steven Barash highlights the critical role of digital infrastructure and why treating data as an asset is key in scaling cell and gene therapy manufacturing. He offers a bold vision for future-proofing biomanufacturing and ensuring patient access through data-first strategies.
The State of Biomanufacturing Today: Why Digital Change Can’t Wait
In this POV, Steven Barash explains why modernizing digital infrastructure isn’t optional—it’s essential to eliminating delays, reducing risks, and keeping pace with biotech innovation.
Take a Look Inside the Latest Version of L7|ESP®, Version 3.4
L7|ESP® includes various new capabilities and enhancements to boost your efficiency and ROI. Read the blog to learn more.